Quantitative coronary angiographic and intravascular ultrasound assessment of a new nonarticulated stent: report from the Advanced Cardiovascular Systems MultiLink stent pilot study
JP Carrozza Jr,
JB Hermiller Jr,
TJ Linnemeier,
JJ Popma,
PG Yock,
GS Roubin,
LS Dean,
RE Kuntz,
L Robertson,
KK Ho,
DE Cutlip,
and
DS Baim
Section of Interventional Cardiology, Beth Israel-Deaconess Medical Center, Boston, Massachusetts 02215, USA.
OBJECTIVES: The purpose of this study was to evaluate the safety, feasibility, optimal deployment technique and 1-year clinical outcome for the Advanced Cardiovascular Systems (ACS) MultiLink stent. BACKGROUND: Optimal stent deployment assessed by quantitative coronary angiography and intravascular ultrasound (IVUS) is associated with improved clinical outcome. METHODS: Forty-nine consecutive patients with a discrete stenosis in a native coronary artery 3 to 4 mm in diameter were treated with the new, balloon-expandable ACS MultiLink stent. Stent expansion was assessed in all patients using quantitative coronary angiography and serial IVUS imaging after 8-, 12- and 16-atm inflations. Clinical follow-up was obtained at 30 days and 1 year. RESULTS: All 49 patients had successful placement of a MultiLink stent without death, emergency coronary artery bypass graft surgery or Q wave myocardial infarction. After placement of the MultiLink stent, the minimal lumen diameter increased from 1.24 to 2.98 mm (p < 0.001), and diameter stenosis decreased from 61% to 7% (p = 0.001). Minimal lumen cross-sectional area by IVUS increased progressively after 8, 12 and 16 atm (5.6 to 6.8 to 7.4 mm2, respectively, p < 0.001). However, only 64% of stents achieved a lumen/reference area ratio > or = 70%. No adverse clinical events occurred by 30 days, and by 1 year only one patient (2.0%) required revascularization of the stented artery. CONCLUSIONS: Treatment of stenoses in native coronary arteries with the MultiLink stent is associated with a high success rate and a low incidence of adverse events by 1 year, despite the fact that the majority of stents did not meet IVUS-defined criteria for "optimal stenting" derived from first-generation devices.
This article has been cited by other articles:
|
|
|
|
 
S. Aziz, J. L Morris, R. A Perry, and R. H Stables
Stent expansion: a combination of delivery balloon underexpansion and acute stent recoil reduces predicted stent diameter irrespective of reference vessel size
Heart,
December 1, 2007;
93(12):
1562 - 1566.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Sonmez, F. Turan, M. Gencbay, M. Degertekin, and N. E. Duran
Long-term (>3 Years) Clinical and Angiographic Outcomes of Coronary Multilink Stent Implantations: A Single Center Experience
Angiology,
September 1, 2004;
55(5):
469 - 477.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. W. Stone, C. L. Grines, D. A. Cox, E. Garcia, J. E. Tcheng, J. J. Griffin, G. Guagliumi, T. Stuckey, M. Turco, J. D. Carroll, et al.
Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction
N. Engl. J. Med.,
March 28, 2002;
346(13):
957 - 966.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Takano, L. A. Yeatman, J. R. Higgins, J. W. Currier, E. Ascencio, K. A. Kopelson, and J. M. Tobis
Optimizing stent expansion with new stent delivery systems
J. Am. Coll. Cardiol.,
November 15, 2001;
38(6):
1622 - 1627.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Hoffmann, P. Haager, G.S. Mintz, G. Kerckhoff, R. Schwarz, A. Franke, J. Vom Dahl, and P. Hanrath
The impact of high pressure vs low pressure stent implantation on intimal hyperplasia and follow-up lumen dimensions; results of a randomized trial
Eur. Heart J.,
November 1, 2001;
22(21):
2015 - 2024.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. P. Carrozza Jr, S. E. Hosley, D. J. C. MD, and D. S. Baim
In Vivo Assessment of Stent Expansion and Recoil in Normal Porcine Coronary Arteries : Differential Outcome by Stent Design
Circulation,
August 17, 1999;
100(7):
756 - 760.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
